Skip to main content

Table 4 M-ANNHEIM clinical staging of chronic pancreatitis

From: Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial

Asymptomatic chronic pancreatitis

 

 0 Stage of subclinical chronic pancreatitis

 

  a Period without symptoms (determination by chance, e.g., autopsy)

 

  b Acute pancreatitis—single episode (possible onset of chronic pancreatitis)

 

  c Acute pancreatitis with severe complicationsa

 

Symptomatic chronic pancreatitis

 

 I Stage without pancreatic insufficiency

 

  a (Recurrent) acute pancreatitis (no pain between episodes of acute pancreatitis)

 

  b Recurrent or chronic abdominal pain (including pain between episodes of acute pancreatitis)

 

  c I a/b with severe complicationsa

 

 II Stage of partial pancreatic insufficiency

 

  a Isolated exocrine (or endocrine) pancreatic insufficiency (without pain)

 

  b Isolated exocrine (or endocrine) pancreatic insufficiency (with pain)

 

  c II a/b with severe complicationsa

 

 III Stage of painful complete pancreatic insufficiency

 

  a Exocrine and endocrine insufficiency (with pain, e.g., requiring analgesic medication)

 

  b III a with severe complicationsa

 

 IV Stage of secondary painless disease (burnout)

 

  a Exocrine and endocrine insufficiency without pain and without severe complicationsa

 

  b Exocrine and endocrine insufficiency without pain and with severe complicationsa

 
  1. aSevere complications are defined as severe organ complications not included in the Cambridge classification. Reversible severe complications include development of ascites, bleeding, pseudoaneurysm, obstruction or stricture of the ductus choledochus, pancreatic fistula and duodenal stenosis. Irreversible severe complications are portal or splenic vein thrombosis with or without portal hypertension, and pancreatic cancer